Description of Acura Pharmaceuticals Inc's Business Segments

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development of innovative technologies for drug delivery and abuse deterrent formulations. The companys primary objective is to create products designed to mitigate the potential for misuse and abuse of medications, particularly those that have high potential for addiction. Below is an extensive overview of Acura Pharmaceuticals segments, products, and services.

Key Segments

1. Pharmaceutical Development:
- Acuras core segment revolves around the research and development of pharmaceutical products. This includes leveraging proprietary technologies to enhance the safety and efficacy of existing medications.

2. Abuse Deterrent Formulations:
- This segment focuses specifically on the development of medications that are engineered to be more difficult to misuse. By integrating abuse deterrent technologies, Acura aims to provide safer options for patients who require pain management and other treatments.

3. Commercialization:
- Once products are developed and approved, the company seeks collaborations or partnerships for the commercialization of its offerings, thereby expanding its market reach and ensuring wider accessibility of its technologies.

Products

1. AXS-05:
- AXS-05 is an investigational drug developed as a treatment for major depressive disorder and other neuropsychiatric conditions. It combines components with established mechanisms of action to provide therapeutic effects while aiming to minimize the potential for abuse.

2. Oxidized alpha-3 (D-Alpha-3-Alpha):
- This is a proprietary formulation that is considered for use in various therapeutic areas. The technology can alter the release of drugs in ways that could help reduce potential misuse while delivering therapeutic benefits.

3. Abuse-Deterrent Technologies:
- Acura has developed various technologies designed to prevent the abuse of drugs. These technologies can be applied to opioids and other medications that are commonly misused.

4. Partnership Products:
- Acura may also partner with other pharmaceutical companies to develop and market abuse-deterrent formulations, utilizing its proprietary technologies in conjunction with established medicinal compounds.

Services

1. Technology Licensing:
- Acura Pharmaceuticals offers licensing agreements for its proprietary drug delivery technologies. These agreements enable other companies to utilize Acuras innovations in their product development efforts.

2. Consulting and Support:
- The company may provide consulting services to other pharmaceutical firms seeking to develop abuse-deterrent products. This can include guidance on formulation technology and regulatory pathways.

3. Collaborative Research:
- Acura engages in collaborations with academic institutions and industry partners to advance research in drug delivery systems, especially focusing on abuse deterrent technologies.

4. Regulatory Expertise:
- Given the complexities involved in bringing pharmaceuticals to market, Acura offers expertise in regulatory affairs, assisting partners in navigating the approval processes required by regulatory bodies.

Conclusion

Acura Pharmaceuticals, Inc. is positioned to play a significant role in the pharmaceutical landscape by prioritizing safety and efficacy in the development of medications. Through its various segments, innovative products, and supportive services, the company addresses critical needs in pain management and associated fields while fostering a commitment to reducing the potential for drug abuse. Its focus on abuse deterrent formulations makes it a key player in addressing the ongoing issues related to prescription drug misuse and addiction.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.